Pharmacological approaches of ADHD
Abstract Body Adults with ADHD describe self-medicating with cannabis. A small number of psychiatrists in the US prescribe cannabis medication for ADHD, despite there being no evidence from trials. The EMA-C trial (Experimental Medicine in ADHD-Cannabinoids) was a pilot randomised placebo-controll...
Main Authors: | R. Cooper, E. Williams, S. Seegobin, C. Tye, J. Kuntsi, P. Asherson |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-04-01
|
Series: | European Psychiatry |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933821002273/type/journal_article |
Similar Items
-
Lateralization of attention in adults with ADHD: Evidence of pseudoneglect
by: Bartosz Helfer, et al.
Published: (2020-01-01) -
Testing for the mediating role of endophenotypes using molecular genetic data in a twin study of ADHD traits
by: Pinto, R, et al.
Published: (2016) -
Shared cognitive impairments and aetiology in ADHD symptoms and reading difficulties.
by: Celeste H M Cheung, et al.
Published: (2014-01-01) -
Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence
by: McCarthy Suzanne, et al.
Published: (2012-12-01) -
The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care
by: McCarthy Suzanne, et al.
Published: (2012-06-01)